# Amgen Inc. (AMGN) — Q2-2015 Earnings Results

**Report date:** 2015-07-30 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2015

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 0.13%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.57 | N/A | +5.85% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their future growth potential despite not providing specific guidance. They noted the importance of innovation in driving results.

**Key quotes:**

> Management highlighted the strength of their product pipeline.

> They emphasized ongoing investments in research and development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock reacted modestly, rising by 0.13%, likely driven by the strong EPS performance and management's positive outlook on their product pipeline. However, the lack of revenue figures and guidance may leave investors cautious.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2015_